Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Antitumor efficacy of PD166285 and PD173074, novel inhibitors of receptor tyrosine kinases, in combination with photodynamic therapy

Antitumor efficacy of PD166285 and PD173074, novel inhibitors of receptor tyrosine kinases, in combination with photodynamic therapy. VII Int. Con. Met. Res. Soc. 1998; 41.


© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.